Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells

Neuroscience

Volumn 278, Issue , 2014, Pages 276-290

  Yang, W N ^a   Ma, K G ^a   Chen, X L ^a   Shi, L L ^b   Bu, G ^c   Hu, X D ^a   Han, H ^a   Liu, Y ^a   Qian, Y H ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Alzheimer's disease; Beta amyloid protein; Mitogen activated protein kinase signaling pathways; Uptake; 7 nicotinic acetylcholine receptor

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BUNGAROTOXIN RECEPTOR; PEPTIDE FRAGMENT; PROTEIN BINDING;

ALZHEIMER DISEASE; HUMAN; METABOLISM; NEUROBLASTOMA; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; HUMANS; MAP KINASE SIGNALING SYSTEM; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 84908157891     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.08.013     Document Type: Article

References (60)

1. Banerjee C., Nyengaard J.R., Wevers A., de Vos R.A.I., Steur E., Lindstrom J., Pilz K., Nowacki S., Bloch W., Schroder H. Cellular expression of alpha 7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease-a stereological approach. Neurobiol Dis 2000, 7:666-672.
2. Basak J.M., Verghese P.B., Yoon H., Kim J., Holtzman D.M. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of A beta uptake and degradation by astrocytes. J Biol Chem 2012, 287:13959-13971.
3. Billings L.M., Oddo S., Green K.N., McGaugh J.L., LaFerla F.M. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
4. Burghaus L., Schutz U., Krempel U., de Vos R.A., Jansen Steur E.N., Wevers A., Lindstrom J., Schroder H. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Mol Brain Res 2000, 76:385-388.
5. Carrasco Serrano C., Viniegra S., Ballesta J.J., Criado M. Phorbol ester activation of the neuronal nicotinic acetylcholine receptor alpha 7 sub-unit gene: involvement of transcription factor Egr-1. J Neurochem 2000, 74:932-939.
6. Christensen D.Z., Kraus S.L., Flohr A., Cotel M.C., Wirths O., Bayer T.A. Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathol 2008, 116:647-655.
7. Criado M., delToro E.D., Carrasco Serrano C., Smillie F.I., Juiz J.M., Viniegra S., Ballesta J.J. Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: a role for transcription factor Egr-1. J Neurosci 1997, 17:6554-6564.
8. D'Andrea M.R., Nagele R.G., Wang H.Y., Peterson P.A., Lee D.H.S. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 2001, 38:120-134.
9. Dafnis I., Stratikos E., Tzinia A., Tsilibary E.C., Zannis V.I., Chroni A. An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide β 42. J Neurochem 2010, 115:873-884.
10. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., Sweatt J.D. β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 2001, 21:4125-4133.
11. Doisy X., Blagbrough I.S., Wonnacott S., Potter B.V.L. Design, synthesis, and biological evaluation of substituted benzoate analogues of the selective nicotinic acetylcholine receptor antagonist, methyllycaconitine. Pharm Pharmacol Commun 1998, 4:313-317.
12. Du H., Guo L., Fang F., Chen D., Sosunov A.A., McKhann G.M., Yan Y., Wang C., Zhang H., Molkentin J.D., Gunn Moore F.J., Vonsattel J.P., Arancio O., Chen J.X., Yan S.D. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008, 14:1097-1105.
13. El Kouhen R., Hu M., Anderson D.J., Li J., Gopalakrishnan M. Pharmacology of α7 nicotinic acetylcholine receptor mediated extracellular signal-regulated kinase signalling in PC12 cells. Br J Pharmacol 2009, 156:638-648.
14. Feld M., Krawczyk M.C., Fustinana M.S., Blake M.G., Baratti C.M., Romano A., Boccia M.M. Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer's disease. J Alzheimers Dis 2014, 40:69-82.
15. Fuentealba R.A., Liu Q., Zhang J., Kanekiyo T., Hu X., Lee J.M., LaDu M.J., Bu G. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Aβ 42 uptake and lysosomal trafficking. PLoS One 2010, 5:e11884.
16. Ge S.N., Ma Y.F., Hioki H., Wei Y.Y., Kaneko T., Mizuno N., Gao G.D., Li J.L. Coexpression of VGLUT1 and VGLUT2 in trigeminothalamic projection neurons in the principal sensory trigeminal nucleus of the rat. J Comp Neurol 2010, 518:3149-3168.
17. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H.X., Greengard P., Relkin N.R. Intraneuronal Aβ 42 accumulation in human brain. Am J Pathol 2000, 156:15-20.
18. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F., Sisodia S.S., Greengard P., Xu H.X. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer Aβ peptides. Proc Natl Acad Sci USA 1999, 96:742-747.
19. Gubbins E.J., Gopalakrishnan M., Li J. α7 nAChR-mediated activation of MAP kinase pathways in PC12 cells. Brain Res 2010, 1328:1-11.
20. Hahn S.S., Tang Q., Zheng F., Zhao S.Y., Wu J.L. GW1929 inhibits alpha 7 nAChR expression through PPAR gamma-independent activation of p38 MAPK and inactivation of P13-K/mTOR: the role of Egr-1. Cell Signal 2014, 26:730-739.
21. Hansson Petersen C.A., Alikhani N., Behbahani H., Wiehager B., Pavlov P.F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., Ankarcrona M. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 2008, 105:13145-13150.
22. Hardy J., Allsop D. Amyloid deposition as the central event the etiology of Alzheimer's disease. Trends Pharmacol Sci 1991, 12:383-388.
23. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
24. Hu X.Y., Crick S.L., Bu G.J., Frieden C., Pappu R.V., Lee J.M. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci USA 2009, 106:20324-20329.
25. Jin P., Choi D.Y., Hong J.T. Inhibition of extracellular signal-regulated kinase activity improves cognitive function in Tg2576 mice. Clin Exp Pharmacol Physiol 2012, 39:852-857.
26. Jolly P.S., Berkowitz P., Bektas M., Lee H.E., Chua M., Diaz L.A., Rubenstein D.S. p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 2010, 285:8936-8941.
27. LaFerla F.M., Green K.N., Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci 2007, 8:499-509.
28. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., Reddy P.H. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006, 15:1437-1449.
29. Manczak M., Calkins M.J., Reddy P.H. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 2011, 20:2495-2509.
30. Markovic D., Punn A., Lehnert H., Grammatopoulos D.K. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2 β endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol Endocrinol 2008, 22:689-706.
31. Mulder S.D., Nielsen H.M., Blankenstein M.A., Eikelenboom P., Veerhuis R. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro. Glia 2014, 62:493-503.
32. Nagele R.G., D'Andrea M.R., Anderson W.J., Wang H.Y. Intracellular accumulation of β-amyloid(1-42) in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 2002, 110:199-211.
33. Nath S., Agholme L., Kurudenkandy F.R., Granseth B., Marcusson J., Hallbeck M. Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-Amyloid. J Neurosci 2012, 32:8767-8777.
34. Nielsen H.M., Mulder S.D., Belien J.A.M., Musters R.J.P., Eikelenboom P., Veerhuis R. Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 2010, 58:1235-1246.
35. Nishitsuji K., Tomiyama T., Ishibashi K., Ito K., Teraoka R., Lambert M.P., Klein W.L., Mori H. The E693 delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells. Am J Pathol 2009, 174:957-969.
36. Oddo S., Billings L., Kesslak J.P., Cribbs D.H., LaFerla F.M. A β immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004, 43:321-332.
37. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421.
38. Paterson D., Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000, 61:75-111.
39. Qian Y.H., Shi L.L., Yang J., Hu X.D., Han H., Liu Y. Internalization of beta amyloid protein in primary cultured cortical neurons in mouse. J Cent South Univ (Med Sci) 2008, 33:1019-1027.
40. Qian Y.H., Hu X., Hua H., Yong L. Morphological observation of cellular uptake of beta amyloid protein in cultured human neuroblastoma cells. J South Med Univ 2009, 29:1857-1859.
41. Qian Y.H., Xiao Q., Chen H., Xu J. Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway. Biochim Biophys Acta Mol Cell Res 2009, 1793:764-771.
42. Reddy P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 2009, 218:286-292.
43. Rushworth J.V., Griffiths H.H., Watt N.T., Hooper N.M. Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem 2013, 288:8935-8951.
44. Selkoe D.J. The molecular pathology of Alzheimer's-disease. Neuron 1991, 6:487-498.
45. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81:741-766.
46. Skovronsky D.M., Doms R.W., Lee V.M.Y. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J Cell Biol 1998, 141:1031-1039.
47. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-β. Nat Neurosci 2005, 8:1051-1058.
48. Takahashi R.H., Almeida C.G., Kearney P.F., Yu F.M., Lin M.T., Milner T.A., Gouras G.K. Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004, 24:3592-3599.
49. Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A., McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D., Hori O., Ogawa S., Stern D.M., Yamada K., Yan S.S. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci USA 2009, 106:20021-20026.
50. Terai K., Iwai A., Kawabata S., Tasaki Y., Watanabe T., Miyata K., Yamaguchi T. Beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 2001, 104:299-310.
51. Umeda T., Tomiyama T., Sakama N., Tanaka S., Lambert M.P., Klein W.L., Mori H. Intraneuronal amyloid beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J Neurosci Res 2011, 89:1031-1042.
52. Wang H.Y., D'Andrea M.R., Nagele R.G. Cerebellar diffuse amyloid plaques are derived from dendritic Aβ 42 accumulations in Purkinje cells. Neurobiol Aging 2002, 23:213-223.
53. Wang H.Y., Lee D.H.S., D'Andrea M.R., Peterson P.A., Shank R.P., Reitz A.B. Beta-amyloid(1-42) binds to α7 nicotinic acetylcholine receptor with high affinity-implications for Alzheimer's disease pathology. J Biol Chem 2000, 275:5626-5632.
54. Wang H.Y., Lee D.H.S., Davis C.B., Shank R.P. Amyloid peptide Aβ (1-42) binds selectively and with picomolar affinity to alpha 7 nicotinic acetylcholine receptors. J Neurochem 2000, 75:1155-1161.
55. Waring J.F., Abel S., Li J., Bitner R.S., Nikkel A.L., Blornme E.A., Anderson D.J., Gopalakrishnan M. Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an alpha 7 nAChR selective agonist. Neurosci Res 2008, 60:266-274.
56. Wirths O., Bayer T.A. Neuron loss in transgenic mouse models of Alzheimer's disease. Int J Alzheimers Dis 2010, 2010:1-6.
57. Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009, 106:14670-14675.
58. Yao L., Song Q., Bai W., Zhang J., Miao D., Jiang M., Wang Y., Shen Z., Hu Q., Gu X., Huang M., Zheng G., Gao X., Hu B., Chen J., Chen H. Facilitated brain delivery of poly(ethylene glycol)-poly (lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound. Biomaterials 2014, 35:3384-3395.
59. Young K.F., Pasternak S.H., Rylett R.J. Oligomeric aggregates of amyloid β peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha 7 nicotinic receptor. Neurochem Int 2009, 55:796-801.
60. Zheng L., Calvo Garrido J., Hallbeck M., Hultenby K., Marcusson J., Cedazo Minguez A., Terman A. Intracellular localization of amyloid-β peptide in SH-SY5Y neuroblastoma cells. J Alzheimers Dis 2013, 37:713-733.